Investor Class Approved In Suit V. Boston Scientific
A judge certified a class of shareholders Tuesday in a long-standing consolidated securities fraud action against Boston Scientific Corp. and several of its executives alleging the biotech company failed to disclose...To view the full article, register now.
Already a subscriber? Click here to view full article